ECSP034474A - NEW TREATMENT - Google Patents

NEW TREATMENT

Info

Publication number
ECSP034474A
ECSP034474A ECSP034474A ECSP034474A EC SP034474 A ECSP034474 A EC SP034474A EC SP034474 A ECSP034474 A EC SP034474A EC SP034474 A ECSP034474 A EC SP034474A
Authority
EC
Ecuador
Prior art keywords
new treatment
antigen
vaccines
vaccine
hepatitis
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Heyder Koen De
Opstel Omer Van
Michelle Serantoni
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of ECSP034474A publication Critical patent/ECSP034474A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Este invento se refiere a un procedimiento para la producción de un antigeno de la hepatitis B adecuado para uso en una vacuna, comprendiendo el procedimiento la purificación del antigeno en presencia de cisteína y a vacunas que comprenden tales antígenos.This invention relates to a process for the production of a hepatitis B antigen suitable for use in a vaccine, the method comprising the purification of the antigen in the presence of cysteine and to vaccines comprising such antigens.

ECSP034474 2001-01-18 2003-02-07 NEW TREATMENT ECSP034474A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0101334A GB0101334D0 (en) 2001-01-18 2001-01-18 Novel compounds

Publications (1)

Publication Number Publication Date
ECSP034474A true ECSP034474A (en) 2003-08-29

Family

ID=9907070

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034474 ECSP034474A (en) 2001-01-18 2003-02-07 NEW TREATMENT

Country Status (2)

Country Link
EC (1) ECSP034474A (en)
GB (1) GB0101334D0 (en)

Also Published As

Publication number Publication date
GB0101334D0 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
UY26882A1 (en) NEW TREATMENT
CY1118492T1 (en) NOROVIRUS VACCINE PHARMACEUTICAL FORMS
EP1504112A4 (en) Development of a preventive vaccine for filovirus infection in primates
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
AU2002355677A1 (en) Antigenic polypeptides
NO20025838D0 (en) Antigenic polypeptides
DK1404821T3 (en) Process for Preparation of L-Amino Acids in the Derivation of Strains of the Enterobacteriaceae Family
DK1326636T3 (en) vaccine Composition
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
MX2009005414A (en) Liquid anti-rabies antibody formulations.
PT1409692E (en) Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
DK1259259T3 (en) Mucosal adjuvant formulation
CR11307A (en) VACCINES
CY1110744T1 (en) Immunosuppressive combination for prophylactic and therapeutic treatment of US C
WO2003066094A3 (en) Hepatitis b vaccines
ATE458496T1 (en) HIV VACCINES AND METHODS OF APPLICATION
CY1112575T1 (en) IMPROVED FCV VACCINATED VACCINES
DE60222296D1 (en) VACCINATED VIRUS AND METHOD FOR THE PRODUCTION THEREOF
HK1056830A1 (en) Mannose as intranasal vaccine adjuvant
ECSP034474A (en) NEW TREATMENT
AR038311A1 (en) SURFACE ANTIGEN OF THE HEPATITIS B VIRUS AS A MUCOSOPT IMMUNOPOTENTIATOR, RESULTS FORMULATIONS
CO2019000942A2 (en) Composition and use of a peptide
ATE324450T1 (en) POLYPEPTIDE THAT INDUCES NEUTRALIZING ANTIBODIES AGAINST HIV
AR027738A1 (en) COMPOSITION COADYUVANTE, COMPOSITIONS OF VACCINES THAT INCLUDE SUCH COMPOSITION COADYUVANTE; PROCEDURE FOR INDUCTION OF IMMUNE IMMUNORESPUESTAS AMMAMIFEROS AND PROCEDURE OF TREATMENT WHERE SUCH VACCINES APPLY
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals